Solid Biosciences Inc. SLDB
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-01-26
Solid Biosciences Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,846,022 | $28.4M | 3.25% |
| BlackRock Finance, Inc. | 1,483,262 | $8.4M | 1.7% |
| Point72 Asset Management, L.P. | 448,008 | $4.5M | 0.51% |
| D. E. Shaw & Co., Inc. | 222,789 | $2.2M | 0.25% |
| AQR CAPITAL MANAGEMENT LLC | 137,085 | $1.4M | 0.16% |
| RENAISSANCE TECHNOLOGIES LLC | 82,100 | $820,179 | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 60,705 | $606,443 | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.